Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country
Journal
Human Vaccines & Immunotherapeutics
ISSN
2164-5515
2164-554X
Date Issued
2015
Author(s)
Giannina Izquierdo
Juan Pablo Torres
M Elena Santolaya
M Teresa Valenzuela
May Chomali
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Subjects
meningococcal disease
;
meningococcal vaccine
;
outbreak
;
cost-effectiveness analysis
;
md
;
meningococcal disease
;
nmen
;
neisseria meningitidis
;
4cmenb
;
serogroup b meningococcal vaccine
;
gdp
;
gross domestic product
;
csf
;
cerebrospinal fluid